1 / 6

Sleep Disorder Market Strategies and Forecasts, 2020 to 2026

Sleep is complex neurological state that helps in restoring energy level in the body. Alterations in the quality and pattern if sleep may cause sleep disorder. Sleep disorder is defined as a sleep problem, which is characterized by snoring, insomnia, depression, and sleep apnea.

priyankauke2013
Download Presentation

Sleep Disorder Market Strategies and Forecasts, 2020 to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sleep Disorder Market Market Set to Exceed $2.61 Billion by 2026 | CAGR 8.0%

  2. Sleep Disorder Market Size to Reach $2.61 Billion by 2026 “Sleep Disorder Market Share, Size, Trends, & Industry Analysis Report, By Disorder (Insomnia, Hypersomnia, Sleep Apnea, Sleep Breathing Disorders, Circadian Rhythm Disorders, Parasomnia, Sleep Movement Disorders); By Device; By Treatment; By Region: Segment Forecast, 2018 - 2026” The sleep disorder market size is anticipated to reach over USD 2.61 billion by 2026 according to a new research published by Polaris Market Research. In 2017, the sleep apnea devices dominated the global market, in terms of revenue. Asia-Pacific is expected to be the Fastest growing contributor to the global market revenue in 2017. Sleep is complex neurological state that helps in restoring energy level in the body. Alterations in the quality and pattern if sleep may cause sleep disorder. Sleep disorder is defined as a sleep problem, which is characterized by snoring, insomnia, depression, and sleep apnea. Recently, in a study it is found that the approximately more than 75% of Americans from the age of 25 to 59 suffer from sleep disorder in the U.S. Sleep disorder is basically characterize by the difficulty in falling asleep, daytime fatigue, lack of concentration, anxiety, and depression. On the other side, increasing morbidity due to sleep disorder has increased the healthcare cost, and related side effects of the drugs, and increasing patent expiries that are used in treating sleep disorders which would impede the market growth during the forecast period. The treatment for include medication, better sleeping habits, and devices. Medicines such as, Hetlioz (tasimelteon) by Vanda Pharmaceuticals, Intermezzo (zolpidem tartrate sublingual tablet) by Transcept Pharmaceuticals, and Silenor (doxepin) by Somaxon Pharma are some of the FDA approved drugs that are observed to be beneficial during the treatment of sleep disorders. Browse Detailed Research Report On Sleep Disorder Market: https://www.polarismarketresearch.com/industry-analysis/sleep-disorder-market The industry is segmented on the basis of disorder type, device, treatment, and geography. Based on disorder type, the market is bifurcated into sleep apnea, sleep breathing disorders, insomnia, hypersomnia, circadian rhythm disorders, parasomnia, and sleep movement disorders. on the basis of devices, the market is segmented into sleep apnea devices, sleep laboratories, and mattresses & pillows. By Treatment, the market is further bifurcated as psychiatric treatment, behavioral treatment, cognitive behavioral therapy, and medication therapy. The market for sleep disorder in North America generated the highest revenue in 2017, and is expected to be the leading region globally during the forecast period. High number of patient population suffering the sleeping disorders is the primary factor accountable for the highest market - 2 -

  3. Sleep Disorder Market Size to Reach $2.61 Billion by 2026 growth. According to the US Department of Health and Human Services reports, approximately 20% Americans are suffering from sleep disorder. Thus, increasing demand for early treatments along with increasing patient pool, and growing patient awareness for proper diagnosis methods are factors boosting the growth in North America. Asia Pacific is estimated to be the fastest growing region in terms of revenue. Growing awareness about sleep disorders and developing healthcare infrastructure are some of the factors that are projected to generate lucrative opportunities for the market in APAC. The major key players operating in the Sleep Disorder industry include GlaxoSmithKline plc, Becton Dickson and Company, Cardinal Health, Natus Medical Incorporated Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., and Teva Pharmaceutical Industries Ltd. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers. Request for sample: https://www.polarismarketresearch.com/industry-analysis/sleep- disorder-market/request-for-sample Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1. Primary data sources - 3 -

  4. Sleep Disorder Market Size to Reach $2.61 Billion by 2026 1.3.2. Secondary data sources 1.4. Key take-away 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Sleep Disorder Market Insights 3.1. Sleep Disorder – Industry snapshot 3.2. Sleep Disorder - Ecosystem analysis 3.3. Sleep Disorder Market Dynamics 3.3.1. Sleep Disorder – Market Forces 3.3.1.1. Sleep Disorder Market Driver Analysis 3.3.1.2. Sleep Disorder Market Restraint/Challenges analysis 3.3.1.3. Sleep Disorder Market Opportunity Analysis 3.4. Industry analysis - Porter's five force 3.4.1. Bargaining power of supplier 3.4.2. Bargaining power of buyer 3.4.3. Threat of substitute 3.4.4. Threat of new entrant 3.4.5. Degree of competition 3.5. Sleep Disorder Market PEST Analysis 3.6. Sleep Disorder Market Value Chain Analysis 3.7. Sleep Disorder Industry Trends 3.8. Competitive Ranking Analysis, 2017 4. Sleep Disorder Market Size and Forecast by Disorder, 2018-2026 4.1. Key Findings 4.2. Insomnia 4.3. Hypersomnia 4.3.1. Insufficient Sleep Syndrome 4.3.2. Narcolepsy 4.4. Sleep Apnea 4.5. Sleep Breathing Disorders 4.6. Circadian Rhythm Disorders 4.7. Parasomnia 4.7.1. Sleep Eating Disorder 4.7.2. Sleep Terror 4.7.3. REM Sleep Behavior Disorder 4.8. Sleep Movement Disorders 4.8.1. Restless Leg Syndrome 4.8.2. Sleep Leg Cramps 5. Sleep Disorder Market Size and Forecast by Device, 2018-2026 5.1. Key Findings 5.2. Sleep Apnea Devices 5.3. Sleep Laboratories 5.4. Mattresses & Pillows 6. Sleep Disorder Market Size and Forecast by Treatment, 2018-2026 6.1. Key Findings 6.2. Psychiatric Treatment 6.3. Behavioral Treatment 6.4. Cognitive Behavioral Therapy 6.5. Medication Therapy 6.5.1. Prescription Drugs - 4 -

  5. Sleep Disorder Market Size to Reach $2.61 Billion by 2026 6.5.2. OTC Drugs 6.5.3. Herbal Drugs 7. Sleep Disorder Market Size and Forecast by Region, 2018-2026 7.1. Key Findings 7.2. North America 7.2.1. U.S. 7.2.2. Canada 7.3. Europe 7.3.1. Germany 7.3.2. UK 7.3.3. France 7.3.4. Italy 7.3.5. Spain 7.3.6. Belgium 7.3.7. Russia 7.3.8. Netherlands 7.3.9. Rest of Europe 7.4. Asia-Pacific 7.4.1. China 7.4.2. India 7.4.3. Japan 7.4.4. Korea 7.4.5. Singapore 7.4.6. Malaysia 7.4.7. Indonesia 7.4.8. Thailand 7.4.9. Philippines 7.4.10. Rest of Asia-Pacific 7.5. Latin America 7.5.1. Brazil 7.5.2. Mexico 7.5.3. Argentina 7.5.4. Rest of LATAM 7.6. Middle East & Africa 7.6.1. UAE 7.6.2. Saudi Arabia 7.6.3. South Africa 7.6.4. Rest of MEA 8. Company Profiles 8.1. GlaxoSmithKline Plc 8.1.1. Overview 8.1.2. Financials 8.1.3. Product Benchmarking 8.1.4. Recent Developments 8.2. Becton Dickson and Company 8.2.1. Overview 8.2.2. Financials 8.2.3. Product Benchmarking 8.2.4. Recent Developments 8.3. Cardinal Health 8.3.1. Overview 8.3.2. Financials - 5 -

  6. Sleep Disorder Market Size to Reach $2.61 Billion by 2026 8.3.3. Product Benchmarking 8.3.4. Recent Developments 8.4. Natus Medical Incorporated. 8.4.1. Overview 8.4.2. Financials 8.4.3. Product Benchmarking 8.4.4. Recent Developments 8.5. Takeda Pharmaceutical Company Limited 8.5.1. Overview 8.5.2. Financials 8.5.3. Product Benchmarking 8.5.4. Recent Developments 8.6. Koninklijke Philips N.V. 8.6.1. Overview 8.6.2. Financials 8.6.3. Product Benchmarking 8.6.4. Recent Developments 8.7. Teva Pharmaceutical Industries Ltd. 8.7.1. Overview 8.7.2. Financials 8.7.3. Product Benchmarking 8.7.4. Recent Developments Access Press Release on Sleep Disorder Market: https://www.polarismarketresearch.com/press-releases/sleep-disorder-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 6 -

More Related